Jamjoom Pharma is expected to continue working towards the goal of increasing its presence within OTC products in Saudi Arabia. New government regulations concerning medicines and increasing health-consciousness can be expected to encourage consumers towards self-medication. This is likely to represent an opportunity for Jamjoom Pharma to continue improving its brand awareness due to its licensing agreements with key international players. Licensing agreements are expected to enable the company...
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
JAMJOOM PHARMA IN CONSUMER HEALTH (SAUDI ARABIA)
LIST OF CONTENTS AND TABLES
Summary 1 Jamjoom Pharma: Key Facts
Summary 2 Jamjoom Pharma: Operational Indicators
Summary 3 Jamjoom Pharma: Competitive Position 2015
Saudi Arabia Infrastructure Report
BMI View: We significantly downgraded our short-term outlook for the Saudi
Arabian construction sector on the back of liquidity in the market severely
drying up, following a reduction in government spending. Beyond 2016 the goals
of Vision 2030 will be key to opening up the infrastructure market with the
potential of private investment
Saudi Arabia Insurance Report
BMI View: Within the non-life segment, growth in premiums through the forecast period will continue to bedriven by developments in two sub-sectors. There should be higher volumes (if not prices) in the motorvehicle insurance sub-sector, thanks to the expansion in the number of vehicles on Saudi Arabia's vehicles.Higher volumes and inflation in heal
Saudi Arabia Pharmaceuticals and Healthcare Report
BMI View: The combined value of Saudi Arabia's pharmaceutical and healthcare
markets is the largest in the Middle East and Africa region. The Kingdom's
National Transformation Program, a key part of Vision 2030, reinstates the
government's commitment to improving healthcare provision in the country.
Nonetheless, the rising burden of non
Saudi Arabia Petrochemicals Report
The Saudi government is targeting national petrochemicals output of 115mn
tonnes in 2016, which represents a 46% increase since 2013. There are 26
petrochemicals projects under construction at a cost of USD15bn while another 42
are planned over the next five years at an estimated cost of USD46bn. However,
there is the ongoing threat fro